Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report.

Duffy, M J; Sturgeon, C; Lamerz, R; Haglund, C; Holubec, V L; Klapdor, R; Nicolini, A; Topolcan, O; Heinemann, V

Duffy, M J; Sturgeon, C; Lamerz, R; Haglund, C; Holubec, V L; Klapdor, R; Nicolini, A; Topolcan, O; Heinemann, V.

Afiliação

Duffy MJ; Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. Electronic address: michael.j.duffy@ucd.ie.
Sturgeon C; Department of Clinical Biochemistry, Royal Infirmary of Edinburgh, Edinburgh, UK.
Lamerz R; Medical Klinik II, Klinikum Grosshadern, Munich, Germany.
Haglund C; Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland.
Holubec VL; Second Department of Internal Medicine, University Hospital, Pilsen, Czech Republic.
Klapdor R; Centre for Clinical and Experimental Tumour Diagnosis and Therapy, Hamburg, Germany.
Nicolini A; Department of Internal Medicine, University of Pisa, Pisa, Italy.
Topolcan O; Second Department of Internal Medicine, University Hospital, Pilsen, Czech Republic.
Heinemann V; Medical Clinic III, Klinikum Grosshadern, Munich, Germany.

Ann Oncol ; 21(3): 441-447, 2010 Mar.

Article em En | MEDLINE | ID: mdl-19690057

Assuntos

Biomarcadores Tumorais/metabolismo; Neoplasias Pancreáticas/metabolismo; Humanos; Neoplasias Pancreáticas/diagnóstico; Neoplasias Pancreáticas/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Biomarcadores Tumorais Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2010 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google